Regulatory & Marketplace v3i4 - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Editorial Archive

The New Life Science Solution and its Implications on Document Management for Pharmaceutical Companies

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume3-Issue4-2011.pdf

28 April 2012 Editorial Archive | Regulatory & Marketplace v3i4 | Volume 3 Issue 4

Continue Reading →

Editorial Archive

United Nations Summit on Non-communicable Diseases

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume3-Issue4-2011-6.pdf

28 April 2012 Editorial Archive | Regulatory & Marketplace v3i4 | Volume 3 Issue 4

Continue Reading →

Editorial Archive

Personalised Medicine & Companion Diagnostic Device Development

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume3-Issue4-2011-5.pdf

28 April 2012 Editorial Archive | Regulatory & Marketplace v3i4 | Volume 3 Issue 4

Continue Reading →

Editorial Archive

The Future of Franco-British Trade Relations

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume3-Issue4-2011-4.pdf

28 April 2012 Editorial Archive | Regulatory & Marketplace v3i4 | Volume 3 Issue 4

Continue Reading →

Editorial Archive

Moving to a Common Interpretation of eSubmission Validation Criteria?

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume3-Issue4-2011-3.pdf

28 April 2012 Editorial Archive | Regulatory & Marketplace v3i4 | Volume 3 Issue 4

Continue Reading →

Editorial Archive

Strategies for Protecting IP

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume3-Issue4-2011-2.pdf

28 April 2012 Editorial Archive | Regulatory & Marketplace v3i4 | Volume 3 Issue 4

Continue Reading →

Future-ready ADCs – advanced vial solutions for superior stability and performance

Alternative Drug Delivery Routes: Opportunities, Challenges, and How to Overcome Them

Bridging the gap between R&D and GMP

Current Edition

Current Edition

Subsection - CDMO

Subsection - Injectables

Subsection - Neurodegenerative Diseases

Subsection - Nasal & Pulmonary

The New Life Science Solution and its Implications on Document Management for Pharmaceutical Companies

United Nations Summit on Non-communicable Diseases

Personalised Medicine & Companion Diagnostic Device Development

The Future of Franco-British Trade Relations

Moving to a Common Interpretation of eSubmission Validation Criteria?

Strategies for Protecting IP

International Pharmaceutical Industry